LIAISON® Meridian H. pylori SA
Automated CLIA assay for qualitative determination of Helicobacter pylori (H.pylori) antigen in human stool samples.
LIAISON® H. pylori IgG
Automated CLIA assay for the qualitative determination of IgG antibodies to Helicobacter pylori in human serum.
Diagnosis, eradication and monitoring of H. pylori infection
Helicobacter pylori (H. pylori) is a bacterium living in the mucus of the human digestive tract and is present in half of the world population. H. pylori infection is a major risk factor for gastric adenocarcinoma. Diagnosis of infection can be achieved by non-invasive methods, such as detection of H. pylori antigens in stool samples. This kind of assay provides a simple alternative to the urea breath test and is an aid in diagnosis of suspected infection and to measure a patient’s post-therapy response.
The “Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States”* (https://doi.org/10.1016/j.cgh.2018.03.013) states that all patient receiving treatment for H. pylori should receive post-treatment confirmation of eradication. The LIAISON® Meridian H. pylori SA test is one of the tests recommended for eradication.
How it works
LIAISON® H. pylori Diagnostic Solution allows the qualitative determination of H. pylori.
Easy handling of stool samples
Simplicity of the process
The use of LIAISON® Quantitative Stool Extraction Device reduces the preparation steps of the extracted stool samples and allows the operator to easily handle the stool, thus saving time.
Full complete diagnostic approach
LIAISON® Meridian H. pylori SA and LIAISON®H. pylori IgG provide rapid results (30 minutes for each). These assays allow doctors to immediately start appropriate treatment for patient who test positive, thus helping to improve the effectiveness of therapy.
The LIAISON® Meridian H. pylori SA test is known for its high precision in detecting the H.pylori antigen in patient's stools. Thanks to its high sensitivity, the test can detect the presence of H.pylori even in small quantities, thus ensuring an accurate diagnosis.
Why use LIAISON® H. pylori Diagnostic Solution
LIAISON® H. pylori SA is a test that avoids invasive examinations such as endoscopy.
Evaluation of treatment effectiveness
After H. pylori infection treatment, LIAISON® Meridian H. pylori SA can be used to evaluate the effectiveness of the therapy.
Monitoring of the risk of recurrence
LIAISON® Meridian H. pylori SA can also be used to monitor the risk of recurrence after an antibiotical treatment, reducing the risk of antibiotic resistance.
No interfering substance
External substances and diet do not interfere with determination of presence of H. pylori.
To be used on
Designed for both specialty and routine tests, the LIAISON® XL immunoassay analyzer helps your laboratory handle multiple patients and tests simultaneously. LIAISON® systems are trustworthy, intuitive and deliver automated continuous operation with minimal user intervention. The result is reduced turnaround time, optimal cost management and unmatched growth potential.
Designed for large laboratories. Fuse the benefits of high throughput and high sensitivity within a powerful and fully automated system that can seamlessly connect to facilitate Total Laboratory Automation.
More details about our diagnostic solutions
Login to Dialog for additional resources
Login to our repository for instructions for use and user manuals, assay information, protocols and much more.
Get in touch
If you need any information about our products, contact our specialists.
Need any help?
Get help with Diasorin products and services.